Many users also experience improved recovery times from workouts and enhanced exercise performance
Many people on GLP-1 meds find that excessive fat makes them feel queasy
[21] Those who may have adrenal fatigue, those who are often stressed, and those with the MTHFR gene variation and high homocysteine levels, may benefit from an activated or methylated version of folate, mainly because food alone does not provide sufficient levels
The consequent reduction in methylmalonyl-CoA mutase activity can lead to methylmalonic acidemia
As a result, many patients feel fuller longer after meals
Heidi Wright, practice and policy lead for England at the Royal Pharmaceutical Society (RPS), commented: The addition of pancreatitis warnings to the patient leaflet is an important reminder that while GLP-1 [glucagon-like peptide-1] receptor agonists can be highly effective, they are not without risks. Awareness of those risks among patients and healthcare professionals is essential, she said, encouraging clinicians and patients to report any adverse side effects to the Yellow Card scheme